Multicenter, Randomized Study of the Effectiveness of Basiliximab in Avoiding Addition of Steroids to Cyclosporine A Monotherapy in Renal Transplant Recipients

Abstract

These findings demonstrate that the addition of basiliximab significantly reduces the need to modify the initial treatment regimen in patients scheduled to receive steroid-free CsA therapy, suggesting that basiliximab induction may be useful as a strategy in other steroid-avoidance regimens.